Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMC1P12 encodes a processed pseudogene found in the human genome at chromosome 1p12 (1:118614333-118615646), with HGNC accession 644094[1][2][6]. It is not protein-coding and does not generate a functional protein. As a pseudogene, it does not participate in biological processes, disease pathology, or pharmacological drug action[1][2][6]. Because it is not a functional protein or bioactive macromolecule, it is not considered a therapeutic target, nor does it have documented biomarkers, disease associations, or safety concerns. There are no documented interacting drugs or mechanisms of action with respect to patient treatment or drug discovery. Summary: PSMC1P12 is a non-functional genomic element derived from a gene duplication or retrotransposition event and classified as a processed pseudogene. It does not encode a working protein and has no role as a therapeutic target or receptor in human disease or pharmacology[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome 26S subunit, ATPase 1 pseudogene 12 (PSMC1P12).